Coronary drug-coated balloons
Balloons coated with an antiproliferative drug, used in coronary arteries.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 18, 13, 22, 24, 45.
New guidelines and consensus this year
All papers from the last 12 months
359 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Clinical outcomes of intravascular imaging-guided versus angiography-guided drug-coated balloon angioplasty for de novo coronary lesionsInt J Cardiol2026 Oct 15PMID 42409288
- Stent-Free Sirolimus DCB for Left Main STEMI: Acute and Long-Term OCT Follow-UpJACC Case Rep2026 Oct 14PMID 42559777
- Corrigendum to The European Bifurcation Club randomised trial of stepwise provisional stenting versus Drug Coated Balloon therapy for non-left main true coronary bifurcations: The EBC DCB Trial American Heart Journal: Volume 300, October 2026, 107463Am Heart J2026 Oct 10PMID 42858553
- 2026 revised CVIT clinical expert consensus on drug coated balloons for coronary artery diseaseCardiovasc Interv Ther2026 Oct 9PMID 42853478Review
- Durable Vessel Patency Achieved by Drug-Coated Balloon-Only Percutaneous Coronary Intervention in Triglyceride Deposit CardiomyovasculopathyJACC Case Rep2026 Oct 9PMID 42853169
- Recurrent Revascularization Failure in a Patient with Complex Coronary SubstrateJ Clin Med2026 Oct 6PMID 42882171
- Percutaneous coronary intervention using sirolimus-eluting balloons in patients at high bleeding risk: the SELUTION DeNovo HBR substudyEuroIntervention2026 Oct 5PMID 42837205RCT
- Stepwise dual antiplatelet therapy de-escalation versus standard therapy for 12 months in patients with bifurcation lesions undergoing drug-coated balloon angioplasty: Insights from the REC-CAGEFREE II trialInt J Cardiol2026 Oct 4PMID 42830132
- Clinical outcomes of intravascular ultrasound-guided drug-coated balloon angioplasty for acute coronary syndrome: A single-center retrospective cohort studyMedicine (Baltimore)2026 Oct 2PMID 42826327
- Drug-Coated Balloon for Diffuse Coronary Artery DiseaseJACC Asia2026 OctPMID 42841563
More cardiology trends
All specialties →Semaglutide and cardiovascular outcomes
Research on semaglutide and major cardiovascular events.
Finerenone
A non-steroidal mineralocorticoid receptor antagonist studied in kidney disease and heart failure.
Left atrial appendage occlusion
Closing the left atrial appendage with a device to reduce stroke risk in atrial fibrillation.
Photon-counting CT
A newer CT detector technology, studied for cardiac and coronary imaging.
Conduction system pacing
Pacing the heart's own conduction system, such as the left bundle branch area.
Key point: Conduction system pacing may offer potential advantages over biventricular pacing in patients indicated for CRT; confirmation in larger randomized clinical trials is required.
GLP-1 agonists in heart failure
Studies of GLP-1 receptor agonists such as semaglutide in patients with heart failure.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"drug-coated balloon*"[tiab] AND coronary[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.